Helena M. A. Feenstra

Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial

Thomas J. van Rijssen, Elon H. C. van Dijk, Roula Tsonaka et al. · American Journal of Ophthalmology · 2021 · 96 citations · Full text

Engineering, Dermatology, Pharmacology +10

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Helena M. A. Feenstra, Roselie M.H. Diederen, Martine J. C. M. Lamme et al. · Retina · 2023 · 24 citations · Full text

Health Professions, Ophthalmology, Vision Science +17

Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients

Helena M. A. Feenstra, Elon H. C. van Dijk, Thomas J. van Rijssen et al. · Ophthalmology Retina · 2022 · 19 citations · Full text

Medicine, Ophthalmology, Pharmacology +7

EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Helena M. A. Feenstra, Leo C. Hahn, Thomas J. van Rijssen et al. · Retina · 2021 · 16 citations · Full text

Medicine, Ophthalmology, Vision Science +15

BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY

Lorenzo Ferro Desideri, Rodrigo Anguita, Lieselotte Berger et al. · Retina · 2023 · 16 citations · Full text

Medicine, Ophthalmology, Vision Science +17